Literature DB >> 35704103

Proteoglycan 4 is present within the dura mater and produced by mesenchymal progenitor cells.

Sathvika Mudigonda1, Sophia Shah1,2, Nabangshu Das1, Jessica May Corpuz1,2, Nicoletta Ninkovic1, Nedaa Al-Jezani1, T Michael Underhill3, Paul T Salo1,4, Alim P Mitha2,5,6, Frank G Lyons4, Roger Cho4, Tannin A Schmidt7, Antoine Dufour1,2,6,8, Roman J Krawetz9,10,11,12.   

Abstract

Mesenchymal progenitor cells (MPCs) have been recently identified in human and murine epidural fat and have been hypothesized to contribute to the maintenance/repair/regeneration of the dura mater. MPCs can secrete proteoglycan 4 (PRG4/lubricin), and this protein can regulate tissue homeostasis through bio-lubrication and immunomodulatory functions. MPC lineage tracing reporter mice (Hic1) and human epidural fat MPCs were used to determine if PRG4 is expressed by these cells in vivo. PRG4 expression co-localized with Hic1+ MPCs in the dura throughout skeletal maturity and was localized adjacent to sites of dural injury. When Hic1+ MPCs were ablated, PRG4 expression was retained in the dura, yet when Prx1+ MPCs were ablated, PRG4 expression was completely lost. A number of cellular processes were impacted in human epidural fat MPCs treated with rhPRG4, and human MPCs contributed to the formation of epidural fat, and dura tissues were xenotransplanted into mouse dural injuries. We have shown that human and mouse MPCs in the epidural/dura microenvironment produce PRG4 and can contribute to dura homeostasis/repair/regeneration. Overall, these results suggest that these MPCs have biological significance within the dural microenvironment and that the role of PRG4 needs to be further elucidated.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Dura; Epidural fat; Mesenchymal progenitor cells; Proteoglycan 4

Mesh:

Substances:

Year:  2022        PMID: 35704103     DOI: 10.1007/s00441-022-03647-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   4.051


  47 in total

Review 1.  Adipose-derived stem cells and their potential to differentiate into the epithelial lineage.

Authors:  Patrick C Baer
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

2.  Andromeda: a peptide search engine integrated into the MaxQuant environment.

Authors:  Jürgen Cox; Nadin Neuhauser; Annette Michalski; Richard A Scheltema; Jesper V Olsen; Matthias Mann
Journal:  J Proteome Res       Date:  2011-02-22       Impact factor: 4.466

3.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

4.  Absence of Proteoglycan 4 (Prg4) Leads to Increased Subchondral Bone Porosity Which Can Be Mitigated Through Intra-Articular Injection of PRG4.

Authors:  Saleem Abubacker; Priyatha Premnath; Anchita Shonak; Catherine Leonard; Sophia Shah; Ying Zhu; Gregory D Jay; Tannin A Schmidt; Steven Boyd; Roman Krawetz
Journal:  J Orthop Res       Date:  2019-06-26       Impact factor: 3.494

5.  Distinct Regulatory Programs Control the Latent Regenerative Potential of Dermal Fibroblasts during Wound Healing.

Authors:  Sepideh Abbasi; Sarthak Sinha; Elodie Labit; Nicole L Rosin; Grace Yoon; Waleed Rahmani; Arzina Jaffer; Nilesh Sharma; Andrew Hagner; Prajay Shah; Rohit Arora; Jessica Yoon; Anowara Islam; Aya Uchida; Chih Kai Chang; Jo Anne Stratton; R Wilder Scott; Fabio M V Rossi; T Michael Underhill; Jeff Biernaskie
Journal:  Cell Stem Cell       Date:  2020-08-04       Impact factor: 24.633

6.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

Review 7.  Lubricin: a novel potential biotherapeutic approaches for the treatment of osteoarthritis.

Authors:  Jia-Peng Bao; Wei-Ping Chen; Li-Dong Wu
Journal:  Mol Biol Rep       Date:  2010-01-23       Impact factor: 2.316

8.  Anti-lubricin monoclonal antibodies created using lubricin-knockout mice immunodetect lubricin in several species and in patients with healthy and diseased joints.

Authors:  Minrong Ai; Yajun Cui; Man-Sun Sy; David M Lee; Ling Xiu Zhang; Katherine M Larson; Kyle C Kurek; Gregory D Jay; Matthew L Warman
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

9.  Isolation and Characterization of an Adult Stem Cell Population from Human Epidural Fat.

Authors:  Nedaa Al-Jezani; Roger Cho; Anand O Masson; Brian Lenehan; Roman Krawetz; Frank G Lyons
Journal:  Stem Cells Int       Date:  2019-03-17       Impact factor: 5.443

10.  The interaction of lubricin/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid.

Authors:  Ali Alquraini; Steven Garguilo; Gerard D'Souza; Ling X Zhang; Tannin A Schmidt; Gregory D Jay; Khaled A Elsaid
Journal:  Arthritis Res Ther       Date:  2015-12-04       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.